Quadrant Capital Group’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.59M | Buy |
8,431
+297
| +4% | +$62.6K | 0.05% | 369 |
|
|
2025
Q4 | $1.62M | Buy |
8,134
+58
| +0.7% | +$11.7K | 0.05% | 330 |
|
|
2025
Q3 | $1.64M | Sell |
8,076
-134
| -2% | -$23.8K | 0.05% | 308 |
|
|
2025
Q2 | $1.44M | Buy |
8,210
+646
| +9% | +$97.2K | 0.05% | 321 |
|
|
2025
Q1 | $1.02M | Buy |
7,564
+5,286
| +232% | +$696K | 0.04% | 378 |
|
|
2024
Q4 | $288K | Sell |
2,278
-74
| -3% | -$11K | 0.02% | 500 |
|
|
2024
Q3 | $391K | Sell |
2,352
-24
| -1% | -$3.63K | 0.03% | 415 |
|
|
2024
Q2 | $316K | Buy |
2,376
+110
| +5% | +$13.2K | 0.02% | 465 |
|
|
2024
Q1 | $238K | Buy |
2,266
+28
| +1% | +$2.52K | 0.02% | 552 |
|
|
2023
Q4 | $169K | Sell |
2,238
-282
| -11% | -$17.9K | 0.01% | 687 |
|
|
2023
Q3 | $166K | Buy |
2,520
+30
| +1% | +$2.24K | 0.02% | 607 |
|
|
2023
Q2 | $203K | Buy |
2,490
+102
| +4% | +$7.26K | 0.02% | 514 |
|
|
2023
Q1 | $142K | Buy |
2,388
+1,004
| +73% | +$55.8K | 0.01% | 654 |
|
|
2022
Q4 | $67.5K | Buy |
1,384
+727
| +111% | +$33.6K | 0.01% | 995 |
|
|
2022
Q3 | $34K | Buy |
657
+39
| +6% | +$2.31K | ﹤0.01% | 1261 |
|
|
2022
Q2 | $32K | Buy |
618
+13
| +2% | +$905 | ﹤0.01% | 1074 |
|
|
2022
Q1 | $52K | Buy |
605
+56
| +10% | +$4.6K | 0.01% | 898 |
|
|
2021
Q4 | $45K | Sell |
549
-5
| -0.9% | -$365 | 0.01% | 969 |
|
|
2021
Q3 | $37K | Buy |
554
+4
| +0.7% | +$284 | 0.01% | 980 |
|
|
2021
Q2 | $37K | Buy |
550
+6
| +1% | +$372 | 0.01% | 968 |
|
|
2021
Q1 | $28K | Buy |
544
+11
| +2% | +$556 | ﹤0.01% | 1038 |
|
|
2020
Q4 | $21K | Sell |
533
-7
| -1% | -$226 | ﹤0.01% | 1081 |
|
|
2020
Q3 | $13K | Buy |
540
+7
| +1% | +$179 | ﹤0.01% | 1129 |
|
|
2020
Q2 | $10K | Sell |
533
-1,089
| -67% | -$21.5K | ﹤0.01% | 1341 |
|
|
2020
Q1 | $24K | Buy |
1,622
+93
| +6% | +$2.67K | ﹤0.01% | 1211 |
|
|
2019
Q4 | $56K | Sell |
1,529
-17
| -1% | -$509 | 0.01% | 1281 |
|
|
2019
Q3 | $33K | Buy |
1,546
+934
| +153% | +$19.9K | 0.01% | 1400 |
|
|
2019
Q2 | $11K | Hold |
612
| – | – | ﹤0.01% | 1785 |
|
|
2019
Q1 | $16K | Buy |
612
+65
| +12% | +$1.6K | ﹤0.01% | 1602 |
|
|
2018
Q4 | $8K | Hold |
547
| – | – | ﹤0.01% | 1480 |
|
|
2018
Q3 | $14K | Hold |
547
| – | – | ﹤0.01% | 1151 |
|
|
2018
Q2 | $18K | Hold |
547
| – | – | 0.01% | 1013 |
|
|
2018
Q1 | $13K | Hold |
547
| – | – | ﹤0.01% | 1151 |
|
|
2017
Q4 | $7K | Buy |
547
+91
| +20% | +$1.28K | ﹤0.01% | 1360 |
|
|
2017
Q3 | $7K | Hold |
456
| – | – | ﹤0.01% | 1347 |
|
|
2017
Q2 | $8K | Buy |
+456
| New | +$7.96K | ﹤0.01% | 1185 |
|
|
2016
Q3 | – | Sell |
-46
| Closed | -$1K | – | 2074 |
|
|
2016
Q2 | $1K | Buy |
+46
| New | +$1.36K | ﹤0.01% | 1767 |
|
|
2016
Q1 | – | Sell |
-31
| Closed | – | – | 1978 |
|
|
2015
Q4 | $0 | Buy |
31
+9
| +41% | +$295 | ﹤0.01% | 1694 |
|
|
2015
Q3 | $0 | Sell |
22
-28
| -56% | -$1.45K | ﹤0.01% | 1380 |
|
|
2015
Q2 | $2K | Buy |
+50
| New | +$2.55K | ﹤0.01% | 987 |
|
Other funds holding THC
VPM
VCM
LPC
Quadrant Capital Group's THC Position: Q1 2026 in Review
Quadrant Capital Group increased its Tenet Healthcare (THC) stake by 3.7% in Q1 2026, buying an estimated $62.6K and bringing the position to 8,431 shares worth $1.59M. The position accounts for 0.05% of the portfolio, ranked #369.
Quadrant Capital Group first reported a position in THC in Q2 2015 and has held it in 40 quarters since. The position peaked at $1.64M in Q3 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- Quadrant Capital Group held 8,431 shares of Tenet Healthcare worth $1.59M as of Q1 2026.
- Quadrant Capital Group bought 297 Tenet Healthcare shares in Q1 2026, an estimated $62.6K.
- Tenet Healthcare made up 0.05% of Quadrant Capital Group's portfolio in Q1 2026, its #369 holding.
- Quadrant Capital Group first reported a position in Tenet Healthcare in Q2 2015 and has held it in 40 quarters since.
- Quadrant Capital Group's Tenet Healthcare position peaked at $1.64M in Q3 2025.
- 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.